A new study has found that biologic class and treatment sequencing influences psoriatic arthritis risk in patients with ...

Patients with active psoriatic arthritis who have an inadequate response to TNF inhibitors, mainly those with elevated ...

European Commission approves Bristol Myers Squibb’s Sotyktu for the treatment of active psoriatic arthritis in adults: Princeton, New Jersey Monday, May 11, 2026, 15:00 Hrs [IST ...

Whole-body effects: Psoriasis triggers systemic inflammation that can affect organs, joints, and overall energy, not just the skin. Linked conditions: It’s associated with psoriatic arthritis, mental ...

PIP is now worth up to £778 every four-week period for those on the higher rates of the daily living and mobility components.

Bristol Myers Squibb today announced that the European Commission has granted approval to Sotyktu (deucravacitinib), alone or in combination with methotrexate, for the treatment of active psoriatic ...

A 27-year-old woman from Colchester living with psoriatic arthritis has become the face of a national campaign to raise ...

Misconceptions about psoriatic arthritis can make it difficult to diagnose and explain to others.

Arthritis Action Now unites 21 organizations, more than 100,000 patients, researchers, clinicians and advocates to transform arthritis research and care in Canada TORONTO, April 08, 2026 (GLOBE ...

Ixekizumab plus tirzepatide (IXE+TZP) shows significant benefits over ixekizumab (IXE) alone in adults with active psoriatic arthritis (PsA) who are overweight or have obesity, according to a study ...

Jon Jones still views himself as one of the baddest men on the planet. The former two-weight UFC champion recently revealed that he is battling a severe case of arthritis and is eligible for a hip ...